NCT01230736View on ClinicalTrials.gov

Safety and Efficacy of Changing to DuoTrav From Prior Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Glaucoma

Interventions

DRUG

Travoprost 0.004%/Timolol 0.5% Fixed Combination eye drops solution (Duotrav®)

One drop in study eye(s) once daily for 8 weeks

Trial Locations (1)

97421

Schweinfurt

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY